Live Breaking News & Updates on Biocon ltd

Stay informed with the latest breaking news from Biocon ltd on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Biocon ltd and stay connected to the pulse of your community

Biocon Leads India Push Into Weight Loss Drugs as Patents Begin to Lapse

Biocon Leads India Push Into Weight Loss Drugs as Patents Begin to Lapse
bloomberg.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bloomberg.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , Bengaluru , Karnataka , India , Novo-nordisk , Biocon-ltd ,

Biocon leads India push into weight loss drugs as patents lapse

The Bengaluru-based firm has scored an early win among its peers with the UK approval for the first generic version of liraglutide injectible, which is losing patent protection in November.

Bengaluru , Karnataka , India , United-kingdom , Eli-lilly , Kiran-mazumdar-shaw , Siddharth-mittal , Novo-nordisk-ozempic , Novo-nordisk , Peter-bains , Biocon , Reddy-laboratories-ltd

Weight-loss medicines: Biocon eyes a $100 billion jackpot with weighty pivot

Weight-loss drugs: Biocon Ltd. is shifting focus to anti-obesity therapies as patents for key medications expire, leading to a surge in generic supply. The Bengaluru-based company secured UK approval for the first generic version of liraglutide injectible, positioning itself as a leader in this evolving market.

India , Bengaluru , Karnataka , United-kingdom , Siddharth-mittal , Novo-nordisk , Eli-lilly , Novo-nordisk-ozempic , Kiran-mazumdar-shaw , Peter-bains , Reddy-laboratories-ltd , Biocon